Norwalk Leslie V
SEC insider (Form 3/4/5 filer). CIK 0001533568. Director at NEUROCRINE BIOSCIENCES INC (NBIX) and 3 other issuers. 24 reported Form 4/5 transactions since Sep 2024; latest on Jul 29, 2026. Located in SAN DIEGO, CA.
Companies Norwalk Leslie V has filed insider reports for
- NEUROCRINE BIOSCIENCES INC (NBIX): Director
- ARVINAS, INC. (ARVN): Director
- CVS HEALTH Corp (CVS): Director
- GLOBUS MEDICAL INC (GMED): Director
Norwalk Leslie V
CIK: 0001533568
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Jul 29, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect842 shares at avg. $139.43$117K - Jul 28, 2026NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect1.3K shares at avg. $182.01$228K - Jun 24, 2026ARVN
ARVINAS, INC.
AwardDirect15.5K shares- - Jun 4, 2026NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect1.3K shares at avg. $168.06$210K - May 27, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectNon-Qualified Stock Option
2.6K shares- - May 27, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectRestriced Stock Unit
1.3K shares- - May 21, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect1.7K shares- - May 14, 2026CVS
CVS HEALTH Corp
AwardDirect1.4K shares at avg. $97.15$141K - May 12, 2026NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect3.8K shares at avg. $155.01$591K - Jan 21, 2026GMED
GLOBUS MEDICAL INC
AwardDirectStock Option (Right to Buy Class A Common Stock)
15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2026 |  NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 842 | $139.43 | $117,400 | Direct |
| Jul 28, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Sale | 1,250 | $182.01 | $227,508 | Direct |
| Jun 24, 2026 |  ARVN ARVINAS, INC. | Award | 15,527 | - | $0 | Direct |
| Jun 4, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Sale | 1,250 | $168.06 | $210,072 | Direct |
| May 27, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award Non-Qualified Stock Option | 2,624 | - | - | Direct |
| May 27, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award Restriced Stock Unit | 1,284 | - | - | Direct |
| May 21, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 1,659 | - | $0 | Direct |
| May 14, 2026 |  CVS CVS HEALTH Corp | Award | 1,447 | $97.15 | $140,576 | Direct |
| May 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Sale | 3,810 | $155.01 | $590,601 | Direct |
| Jan 21, 2026 |  GMED GLOBUS MEDICAL INC | Award Stock Option (Right to Buy Class A Common Stock) | 15,000 | - | - | Direct |
1-10 of 24 transactions